本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美第奇新星生物技术

1.23
+0.01000.82%
盘后1.230.00000.00%16:10 EDT
成交量:6.64万
成交额:8.11万
市值:6,032.69万
市盈率:-5.11
高:1.23
开:1.20
低:1.20
收:1.22
52周最高:2.55
52周最低:1.13
股本:4,904.62万
流通股本:4,208.10万
量比:2.07
换手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-0.2408
每股收益(LYR):-0.2253
净资产收益率:-22.66%
总资产收益率:-15.09%
市净率:1.29
市盈率(LYR):-5.46

数据加载中...

2025/08/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/01

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/11

重要事件披露

Form 8-K - Current report
2025/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report